TW200813070A - Antiviral agents - Google Patents
Antiviral agents Download PDFInfo
- Publication number
- TW200813070A TW200813070A TW096125693A TW96125693A TW200813070A TW 200813070 A TW200813070 A TW 200813070A TW 096125693 A TW096125693 A TW 096125693A TW 96125693 A TW96125693 A TW 96125693A TW 200813070 A TW200813070 A TW 200813070A
- Authority
- TW
- Taiwan
- Prior art keywords
- substituted
- group
- methyl
- compound
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83104006P | 2006-07-14 | 2006-07-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200813070A true TW200813070A (en) | 2008-03-16 |
Family
ID=38742551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW096125693A TW200813070A (en) | 2006-07-14 | 2007-07-13 | Antiviral agents |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2044083A1 (ja) |
JP (1) | JP2009543807A (ja) |
KR (1) | KR20090033881A (ja) |
CN (1) | CN101490058A (ja) |
AR (1) | AR062258A1 (ja) |
AU (1) | AU2007272441A1 (ja) |
BR (1) | BRPI0714346A2 (ja) |
CA (1) | CA2657651A1 (ja) |
MX (1) | MX2009000513A (ja) |
PE (1) | PE20080427A1 (ja) |
RU (1) | RU2009105196A (ja) |
TW (1) | TW200813070A (ja) |
WO (2) | WO2008008907A2 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
ATE548044T1 (de) | 2007-05-04 | 2012-03-15 | Vertex Pharma | Kombinationstherapie zur behandlung von hiv- infektionen |
MX2012006877A (es) | 2009-12-18 | 2012-08-31 | Idenix Pharmaceuticals Inc | Inhibidores de virus de hepatitis c de arileno o heteroarileno 5, 5 - fusionado. |
WO2012087833A1 (en) * | 2010-12-22 | 2012-06-28 | Abbott Laboratories | Hepatitis c inhibitors and uses thereof |
US20120252721A1 (en) * | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
FR3008975A1 (fr) * | 2013-07-23 | 2015-01-30 | Servier Lab | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
RU2546006C1 (ru) | 2014-03-07 | 2015-04-10 | Римма Ильинична Ашкинази | Противовирусное средство |
WO2016118043A1 (ru) | 2015-01-20 | 2016-07-28 | Виктор Вениаминович ТЕЦ | Гемостатическое средство |
US10167293B2 (en) * | 2016-05-26 | 2019-01-01 | Bayer Pharma Aktiengesellschaft | [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones |
US11285170B2 (en) | 2017-05-24 | 2022-03-29 | Viktor Veniaminovich Tets | Fractionated antimicrobial compositions and use thereof |
MX2023012110A (es) * | 2021-04-16 | 2023-10-24 | Gilead Sciences Inc | Compuestos de tienopirrol. |
CN117957234A (zh) | 2021-09-10 | 2024-04-30 | 吉利德科学公司 | 噻吩并吡咯化合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1401825E (pt) * | 2001-06-11 | 2009-10-23 | Virochem Pharma Inc | Compostos e métodos para o tratamento ou para a prevenção de infecções com flavivírus |
RU2375350C2 (ru) * | 2003-06-04 | 2009-12-10 | Смитклайн Бичам Корпорейшн | Азотсодержащие производные гетероарила |
-
2007
- 2007-07-12 MX MX2009000513A patent/MX2009000513A/es not_active Application Discontinuation
- 2007-07-12 RU RU2009105196/04A patent/RU2009105196A/ru not_active Application Discontinuation
- 2007-07-12 WO PCT/US2007/073386 patent/WO2008008907A2/en active Application Filing
- 2007-07-12 WO PCT/US2007/073391 patent/WO2008008912A1/en active Application Filing
- 2007-07-12 CA CA002657651A patent/CA2657651A1/en not_active Abandoned
- 2007-07-12 EP EP07799544A patent/EP2044083A1/en not_active Withdrawn
- 2007-07-12 JP JP2009519699A patent/JP2009543807A/ja active Pending
- 2007-07-12 CN CNA2007800266569A patent/CN101490058A/zh active Pending
- 2007-07-12 AU AU2007272441A patent/AU2007272441A1/en not_active Abandoned
- 2007-07-12 BR BRPI0714346-0A patent/BRPI0714346A2/pt not_active Application Discontinuation
- 2007-07-12 KR KR1020097001707A patent/KR20090033881A/ko not_active Application Discontinuation
- 2007-07-13 AR ARP070103144A patent/AR062258A1/es unknown
- 2007-07-13 PE PE2007000902A patent/PE20080427A1/es not_active Application Discontinuation
- 2007-07-13 TW TW096125693A patent/TW200813070A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007272441A1 (en) | 2008-01-17 |
BRPI0714346A2 (pt) | 2013-03-19 |
WO2008008912A1 (en) | 2008-01-17 |
EP2044083A1 (en) | 2009-04-08 |
WO2008008907A2 (en) | 2008-01-17 |
WO2008008907A3 (en) | 2008-03-20 |
AU2007272441A2 (en) | 2009-03-19 |
CA2657651A1 (en) | 2008-01-17 |
RU2009105196A (ru) | 2010-08-27 |
AR062258A1 (es) | 2008-10-29 |
MX2009000513A (es) | 2009-03-09 |
KR20090033881A (ko) | 2009-04-06 |
CN101490058A (zh) | 2009-07-22 |
JP2009543807A (ja) | 2009-12-10 |
PE20080427A1 (es) | 2008-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200813070A (en) | Antiviral agents | |
KR101653548B1 (ko) | 2-{4-[(3s)-피페리딘-3-일]페닐}-2h-인다졸-7-카복스아미드의 약제학적으로 허용되는 염 | |
ES2524787T3 (es) | Derivados de piridazinona como inhibidores de PARP | |
JP4616831B2 (ja) | Akt活性の阻害剤 | |
US20060211698A1 (en) | Bicyclic heteroaryl derivatives for treating viruses | |
TW591022B (en) | Tetrahydropyridino or piperidino heterocyclic derivatives | |
US20060264430A1 (en) | Pyrazole derivative | |
CA2613261A1 (en) | Heteroaryl derivatives for treating viruses | |
KR20070096038A (ko) | Mglur5 길항제로서 사용하기 위한 피롤리딘 및피페리딘 아세틸렌 유도체 | |
JP2009544622A (ja) | 多環式ウイルス阻害剤 | |
US20190263828A1 (en) | Heteroaromatic compounds as vanin inhibitors | |
WO2005049622A1 (ja) | 5-5員縮合複素環化合物及びそのhcvポリメラーゼ阻害剤としての用途 | |
TW200526606A (en) | Substituted triazole derivatives as oxytocin antagonists | |
US9533999B2 (en) | Fused thiazin-3-ones as KCA3.1 inhibitors | |
AU2016341259A1 (en) | Pyridone derivatives and their use as kinase inhibitors | |
US20080051384A1 (en) | Antiviral agents |